Integer Holdings Corporation

ITGR • Medical - Devices

$126.50

▲ +1.00 (+0.80%)

Current price

EarningsLatest report: Jul 3, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$4.32B

Growth

8.5%

Cash Flow

5/5

Trend

Stable

Evidence

Positive revenue growth · 9.5%Positive free cash flow · 3.03Consistent free cash flow · 5/5Manageable debt level · 0.8Healthy liquidity · 3.32

Financial data as of: Jul 3, 2026, 12:00 AM UTCLast earnings update: Jul 3, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 2:01 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$126.50

Change0.80%

Shares Out34.15M

Market Cap$4.32B

Enterprise Value$5.54B

52W Range62.00 - 126.14

Beta0.64

P/E33.64

P/S2.35

P/B2.51

P/FCF32.89

EV/Sales3.01

Price$126.50

Change0.80%

Shares Out34.15M

Market Cap$4.32B

Enterprise Value$5.54B

52W Range62.00 - 126.14

Beta0.64

P/E33.64

P/S2.35

P/B2.51

P/FCF32.89

EV/Sales3.01

EV/EBITDA17.49

EV/FCF42.22

Earnings Yield2.97%

FCF Yield3.04%

Dividend Yield0.00%

Gross Margin23.06%

Oper. Margin11.33%

Profit Margin5.57%

Debt/Eq0.80

Current Ratio3.32

Quick Ratio2.23

Revenue 5Y8.52%

Target$118.25

Target Upside-6.52%

Target Median$121.00

Target Range104.00 - 127.00

Volume84.02K

Avg Volume717.31K

EPS Surprise-0.01

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

52/100

Financial Strength

Debt, cash, stability

80/100

Growth Potential

Revenue and expansion

60/100

Price Attractiveness

Cheap or expensive today

73/100

Why this score▼

Positive revenue growth · 9.5%Positive free cash flow · 3.03Consistent free cash flow · 5/5Manageable debt level · 0.8Healthy liquidity · 3.32

Analyst view

Analyst sentiment and price target

ITGR

Analyst sentiment

Based on 16 analyst votes · 2026-09-05

75/100

Bullish

Hold

Bearish

Price Target

2026-08-07

Low

$101.00

Mean

$114.80

Median

$115.00

High

$127.00

Company Overview

IPO: 9/29/2000

Industry: Medical - Devices

P/B i: 2.51

Debt / Equity i: 0.80

Operating Margin: 11.33%

Net Margin: 5.57%

ROE i: -

ROIC: -

Financial Health

Score16 / 20

Debt / Equity: 0.80

Current Ratio: 3.32

Quick Ratio: 2.23

Status: Strong

Insider Transactions

Recent executive and insider activity

Metcalf Milo Stephen II

Transaction: 07/06/2026

BUY

Change

+892

Price

Not reported

Filing

07/10/2026

Type

BUY

Metcalf Milo Stephen II

Transaction: 07/06/2026

OTHER

Change

Price

Not reported

Filing

07/10/2026

Type

OTHER

Thor Kirk K

Transaction: 06/30/2026

SELL

Change

-6,120

Price

Not reported

Filing

07/01/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
Metcalf Milo Stephen II	BUY	+892	Not reported	07/06/2026	07/10/2026
Metcalf Milo Stephen II	OTHER	0	Not reported	07/06/2026	07/10/2026
Thor Kirk K	SELL	-6,120	Not reported	06/30/2026	07/01/2026
Thor Kirk K	SELL	-2,409	$93.45	06/30/2026	07/01/2026
Harris John A	BUY	+1,096	Not reported	06/29/2026	07/01/2026
Spence Donald J	BUY	+2,623	Not reported	05/20/2026	05/22/2026
PASSERINI FILIPPO	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Flanagan James Francis	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Antrum Sheila	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Capps Cheryl C	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Jeffers Alvin Tyrone	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Kapito Aaron	BUY	+1,967	Not reported	05/20/2026	05/22/2026
COYLE MICHAEL J	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Hinrichs James F.	BUY	+1,967	Not reported	05/20/2026	05/22/2026
MAXWELL MARTIN C	BUY	+1,967	Not reported	05/20/2026	05/22/2026
Thomas Tommy P	BUY	+666	Not reported	05/18/2026	05/22/2026
Stephens Jim	SELL	-1,472	Not reported	05/15/2026	05/19/2026
Stephens Jim	BUY	+491	Not reported	05/15/2026	05/19/2026
Smith Diron	SELL	-2,063	Not reported	05/08/2026	05/12/2026
Smith Diron	SELL	-503	$88.12	05/08/2026	05/12/2026

About the Company

Integer Holdings Corporation

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Source - link

Peers

ADUS AORT CON HAE INSP LIVN PINC PRCT RXRX UFPT

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?

Integer's $5.7 billion KKR buyout offers shareholders $127 per share in cash, but closing still hinges on stockholder and regulatory approvals.

Zacks Investment Research

Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR

LOS ANGELES--(BUSINESS WIRE)---- $ITGR--Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR.

Business Wire

GMED or ITGR: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Integer (ITGR). But which of these two stocks is more attractive to value investors?

Zacks Investment Research

ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law

Schall, Brown and Schwartz LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv

GuruFocus

ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $ITGR--ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law.

Business Wire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-04-30	1.21	1.2	-0.01
2026-02-19	1.7	1.76	0.06
2025-10-23	1.68	1.79	0.11
2025-07-24	1.57	1.55	-0.02
2025-04-24	1.27	1.31	0.04
2025-02-20	1.46	1.43	-0.03
2024-10-24	1.36	1.43	0.07
2024-07-25	1.24	1.3	0.06
2024-04-25	1.12	1.14	0.02
2024-02-15	1.34	1.39	0.05
2023-10-26	1.05	1.27	0.22
2023-07-27	0.99	1.14	0.15